European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
List of referrals for human medicinal products
Diovan (1219)
| Product name: | Diovan (1219) |
| Also marketed in the EU under the name(s): | Angiosan, Cordinate, Dalzad, Diovane, Kalpress Cardio, Miten Cardio, Novacard, Provas, Rixil, Tareg, Valsartan Novartis, Varexan |
| INN: | Valsartan |
| Indication: | Hypertension: Treatment of hypertension in adults. Recent myocardial infarction: Treatment of clinically stable adult patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction after a recent (12 hours-10 days) myocardial infarction (all except 320 mg film-coated tablets) Heart failure: Treatment of symptomatic heart failure in adult patients when angiotensin converting enzyme (ACE) inhibitors cannot be used, or as add-on therapy to ACE inhibitors when beta-blockers cannot be used. (all except 320 mg film-coated tablets) |
| Marketing Authorisation Holder: | Not available |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 20/04/2010 | Referral | EMEA/H/A-29-PAD/1219 | (2010)2577 of 19/04/2010 |